Publicacións (241) Publicacións nas que participase algún/ha investigador/a

2024

  1. Effectiveness and safety of bictegravir/emtricitabine/tenofovir alafenamide in HIV late presenters

    International Journal of Antimicrobial Agents, Vol. 63, Núm. 1

  2. Laboratory Report of HIV-1 Low-Level Viremia

    Open Forum Infectious Diseases

2023

  1. A Randomized Trial of Dolutegravir Plus Darunavir/ Cobicistat as a Switch Strategy in HIV-1-Infected Patients With Resistance to at Least 2 Antiretroviral Classes

    Open Forum Infectious Diseases, Vol. 10, Núm. 11

  2. Effectiveness and safety of integrase strand transfer inhibitors in Spain: a prospective real-world study

    Frontiers in Cellular and Infection Microbiology, Vol. 13

  3. High Levels of IL-1β, TNF-α and MIP-1α One Month after the Onset of the Acute SARS-CoV-2 Infection, Predictors of Post COVID-19 in Hospitalized Patients

    Microorganisms, Vol. 11, Núm. 10

  4. IP-10 and MIG are sensitive markers of early virological response to HIV-1 integrase inhibitors

    Frontiers in Immunology, Vol. 14

  5. Interleukin 18 (IL-18) and IL-3 in Extracellular Vesicles: Biomarkers for Durable Elite Control of HIV-1

    Journal of Infectious Diseases

  6. Meningococcal carriage in men who have sex with men presenting at a sexual health unit in Spain

    European Journal of Clinical Microbiology and Infectious Diseases, Vol. 42, Núm. 3, pp. 287-296

  7. Plasma Human Immunodeficiency Virus 1 RNA and CD4+T-Cell Counts Are Determinants of Virological Nonsuppression Outcomes with Initial Integrase Inhibitor-Based Regimens: A Prospective RESPOND Cohort Study

    Clinical Infectious Diseases

  8. The factors associated with the trend in incidence of Bacteraemia and associated mortality over 30 years

    BMC Infectious Diseases, Vol. 23, Núm. 1

  9. The interaction between liver cirrhosis, infection by Streptococcus bovis, and colon cancer

    European Journal of Clinical Microbiology and Infectious Diseases, Vol. 42, Núm. 7, pp. 907-912